1.Radiotherapy of brain metastases
Journal of International Oncology 2013;(6):437-440
Brain metastases is a common cause of advanced tumors teeatment failure,and radiotherapy is one of the main treatment modalities.With the development of radiotherapy techniques,the survival and quality of life of patients with brain metastases have been significantly improved.Whole brain radiotherapy,stereotactic radiotherapy as well as the combination are the main treatment options,but the best fraction size,the most optional time and suitable patients need to be further investigated.Novel radiotherapy techniques such as simultaneous integrated boost have been a research hotspot.
2.Current situation of hypopharyngeal cancer radiotherapy
Journal of International Oncology 2014;41(4):264-267
Hypopharyngeal cancer is not common and its prognosis is among the worst in head and neck cancer.Radiation therapy is an important choice of treatment,including radiotherapy alone,radiotherapy combined with surgery and radiotherapy combined with chemotherapy.The improvement of radiation therapy improves the prognosis of hypopharyngeal cancer patients,and radiotherapy combined with surgery is the standard treatment for hypopharyngeal cancer.Nowadays,in order to enhance the preserving rates of the organ and faction,radiotherapy combined with chemotherapy is becoming a research hotspot.
3.Tumor motion and the control methods in precision radiotherapy
Journal of International Oncology 2009;36(7):507-510
Tumor motion can reduce the dose to the target volume while give unnecessary irradiation to the surrounding normal tissues and is an important factor to influence the precision radiotherapy. Many resear-ches find tumor motion exist in the radiotherapy for many tumors in thoracic and abdominal. Its main reason is respiration movement. Nowadays, there are some measurements to control it. The precision of radiotherapy can got further improved through the appropriate control to minimize the disadvantages influence of tumor motion in the precision radiotherapy.
4.Research status of postoperative radiotherapy for non-small cell lung cancer
Chinese Journal of Radiation Oncology 2016;25(1):81-84
A considerable proportion of patients with non small cell lung cancer (NSCLC) require postoperative adjuvant therapy,postoperative radiotherapy is an important part of the treatment,this article review the role and value of postoperative radiotherapy for NSCLC patients in recent years.
5.Controversies over the treatment for stage Ⅲ A-N2 non-small cell lung cancer and related advances
Chinese Journal of Radiation Oncology 2017;26(4):470-473
Stage Ⅲ A non-small cell lung cancer (NSCLC) has high heterogeneity and there are some controversies over the treatment of this disease,especially for patients with stage ⅢA-N2 NSCLC.This article investigates whether preoperative or postoperative radiotherapy can improve the survival of patients with stage ⅢA-N2 NSCLC and evaluates the effect of surgical treatment.
6.Different fractionations of radiotherapy in non-small cell lung cancer
Jing LI ; Yuzhi SONG ; Xueying QIAO
Journal of International Oncology 2012;39(3):215-217
Radiotherapy is an importment local treatment for non-small cell tung cancer. In recent years,with the development of molecular biology and radiotherapy technique and the update of equipment,radiation pattern with different doses segmentation and the concept of the combined therapy including radiotherapy and chemotherapy have been applied in clinic gradually,which get better effects.
7.RADIATION PROGNOSIS OF LOWER THIRD THORACIC ESOPHAGEAL CARCINOMA
Jun WAN ; Ren LI ; Xueying QIAO
Chinese Journal of Radiation Oncology 1992;0(01):-
From October 1969 through December 1981, 3483 esoghageal carcinomas without superficial lymphatic metastasis were treated by 60 Co in our hospital. The radiation dose was over 50Gy and follow-up was over ten years. Results: No significant difference of survival rates was found in various cancer locations in the esophagus combined with the data between our hospital and Xingtai Tumor Hospital, the 5-year survival rates for lower third esophageal cancer were 20.7%~36.4% in surgery group and only 4.3% in radiation group. The 5-year survival rates were also significantly diffrent between radiation group(34.7%) and surgery group (64.9%) for cancer length of
8.Clinical analysis of hydrometra in the elderly women
Qiao ZHANG ; Wei LI ; Linlin MA ; Xueying ZHAO
Chinese Journal of Geriatrics 2011;30(10):842-844
Objective To investigate ultrasonographic features,clinical and histopathologic characteristics of hydrometra in the elderly women.Methods Hysteroscopy endometrial biopsy,dilation and curettage (D&C) and Tao Brush were selectively performed for the endometrial cytologic and histopathologic diagnosis according to the depth of the hydrometra investigated by transvaginal sonography,endometrial thickness and high-risk factors of carcinoma of endometrium in 72 elderly women with hydrometra.Results Among 72 elderly women with hydrometra,9 cases (12.5%) were examined by hysteroscopy,51 cases (70.8%) by D&C and 12 cases (16.7%) by endometrial cytology along with D&C.Histopathologic examination revealed that there were 7 (9.72%) cases with endometrial carcinoma,2 cases (2.8%) with atypical endometrial hyperplasia,6 cases (5.6%) with endometrial benign lesion,14 cases(19.4%)with pyometra and the other 43 cases (59.7%) with normal and simple hydrometra.Conclusions Transvaginal sonography in combination with endometrial cytology are beneficial for screening of endometrial disorders or for drainage of hydrometra in elderly women,decreasing invasive examinations such as D&C.
9.Apoptosis-inducing effect of recombinant adeno-associated virus serotype 8 with TRAIL gene on human colon cancer cell line
Baoguo ZHOU ; Haiquan QIAO ; Liquan TONG ; Shangha PAN ; Xueying SUN
Chinese Journal of General Surgery 1997;0(04):-
Objective To study the apoptosis-inducing effect of recombinant adeno-associated virus serotype 8 with soluble TRAIL gene on human colon cancer cell line HCT116. Method Recombinant adeno-associated virus serotype 8 with TRAIL gene was generated by triple plasmid transfection of HEK293 cells with phosphate calcium precipitation. After infected by recombinant virus, cell growth assay was carried out by counting alive cells after trypan blue exclusion. Alternations of cell morphology was examined by microscopy. Cell apoptosis was detected by DNA laddering. The protein expressions of apoptosis-3 and apoptosis-8 were detected by Western blotting. Result The growth rate of the AAV8-sTRAIL infected HCT116 cells was significantly inhibited. Recombinant virus induced apoptosis in colon tumor cells by triggering caspase cascade, but not in normal human hepatocytes. Conclusion AAV8-sTRAIL efficiently suppresses the growth of human colon cancer cell line HCT116 by inducing apoptosis, with no evident toxicity to normal cell.
10.Prognostic factors of three-dimensional conformal radiotherapy for stage lⅢ non-small cell lung cancer patients aged 70 and over
Xiuming TIAN ; Yuxiang WANG ; Rong QIU ; Hui GE ; Shuchai ZHU ; Xueying QIAO
Chinese Journal of Geriatrics 2017;36(9):970-974
Objective To assess the therapeutic efficacy and prognostic factors in elderly patients with stage Ⅲ non-small cell lung cancer (NSCLC) after three-dimensional conformal radiotherapy (3DCRT).Methods A retrospective analysis of 124 stage Ⅲ NSCLC patients aged 70 or over who had received treatment with 3DCRT was conducted retrospectively in this study.There were 99 male and 25 female patients,with a median age of 74 years(range:70-84).The median dose was 60 Gy(range 50-72 Gy).Eighty-three patients were treated with radiotherapy alone,27 with sequential and 14 with concurrent radiochemotherapy.Results The end date of follow-up was August 30,2013.After 3DCRT,the 1-,3-and 5-year overall survival (OS) were 61.1%,23.8% and13.2 %,respectively,and the median survival time was 18 months.Univariate analysis revealed that gender,obstructive pneumonia,dosage,method of therapy and immediate effect were related to OS(x2 =3.957,6.398,7.147,12.307 and 11.035,respectively;P=0.047,0.011,0.008,0.002 and 0.001,respectively).Multi-variable analysis indicated that age,gender,obstructive pneumonia,dosage and method of therapy were independent prognostic factors for OS.The OS time was longer inpatients who were female,aged over 75,with no obstructive pneumonia or dosage≥ 60 Gy.Compared with radiotherapy alone,sequential radiochemotherapy increased OS while concurrent radiochemotherapy decreased OS.Conclusions Sex,age,obstructive pneumonia and dosage affect the survival of elderly stage Ⅲ NSCLC patients treated with three-dimensional conformal radiotherapy.Concurrent radiochemotherapy should be considered with caution